# Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung

> **NCT05228795** · — · UNKNOWN · sponsor: **Sohag University** · enrollment: 60 (estimated)

## Conditions studied

- Lung Cancer Adenocarcinoma
- Lung Cancer Squamous Cell
- Mesothelioma; Lung

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05228795
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05228795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05228795, "Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05228795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*